5J·

Reallocation: less blue chip, more growth (and risk)

Yesterday I halved my $NOVO B (-0,14 %) - halved my position yesterday and shifted into $WYNN (-0,03 %) .

Position doubled, first entry was in April.

After the first commercial gaming license in the UAE last year, a second resort in the region was approved. So more opportunity, less risk !

The first resort will open its doors in 2027.

Until then, things can continue as they have for the last six months 😅

25.09

Wynn Resorts

Acheté x20 à 107,85 €

2 156,99 €

10 Commentaires

Tenbagger2024@Tenbagger2024

It doesn't look bad.
I am in $LTMC

•

Patrick@patbate

@Artiskon @Tenbagger2024 $EVO is also worth a look. A true free cash flow machine with a currently very favorable level.

•

Utilisateur supprimé

Le commentaire a été supprimé

Spacepanda@Spacepanda

@Allan- I don't sell 😉. Panic selling is not my thing.

••

MEMO@MEMO1993

@Allan- i'm still laughing at seebi, the share is fluctuating around 60 - 30 euros. Profits are logically realized 50 euro mark was an overcoming was also communicated several times by several traders. Long-term investors are investing in several trades and nothing is being done wrong. The market has a lot of potential. Bayer was also declared dead and from the low to now you have also made a decent return, apart from that in the spring when the courts come to an end you will see the shares at 50 euros.

•

Utilisateur supprimé

Le commentaire a été supprimé

MEMO@MEMO1993

@Allan- it's pharma what do you expect? Something good comes into the pipeline and then it's a blockbuster. But they are in a market environment where growth is and always will be necessary unless you can cure it. Name me a pharmaceutical sector that has no ups and downs. If you are not comfortable with such stocks, you should not invest in them. I'm not interested, for example, in selling when I have a good entry or holding it at very low levels and partially saving if there is nothing else that catches my eye on the side. The company was not founded yesterday and is not a 5 billion company. I don't care about lilly either, the market is so big that not even both of them can cover it at the moment. Apart from that, 80% of investors are developing feelings for the company ect. I haven't even considered investing at the highs until around 60. But as I said, keep your hands off pharma if you can't cope with something like this. Besides, everything that happens around us happens non-stop. Tariffs there war there and can affect everything but in the long term the company has delivered see chart. I have earned my money with the company, including dividends, and hold a small position which I will then expand piece by piece at the bottom.

••

Utilisateur supprimé

Le commentaire a été supprimé

MEMO@MEMO1993

On the stock market you can make and lose money with everything, the element has to fit. How many people do you think have cursed how many companies and how much negative sentiment people have carried with them about companies. This is how money is made. Most people can't control that and don't see it. That's why people are often advised to invest in ETFs, because they believe that they can escape the whole thing and invest blindly in it all, etc. There will be many, many more consequences regarding the whole thing and many people will turn their backs on the stock market again. The bottom line is that no matter what you invest in, be it gold, bonds, ETFs, shares, etc., you have to be familiar with the subject and know where the money is going. Don't go to the supermarket and buy everything and stuff yourself with everything you can, but look at what you buy and compare whether the money you pay for the product is worth it or not. And yes, cafe costs 20 euros but on certain days it's -25% and on some days -50%. An old friend has held nestle shares for over 14 years and is up 150% with the position including dividends. Is that a lot? no, not for most people. Is he happy yes he is . I don't want to fill you up with this topic, but I still hope that it was informative.

••